申请人:Merck & Co. Inc.
公开号:US05455239A1
公开(公告)日:1995-10-03
A compound of the formula I is disclosed. ##STR1## R.sup.13 represents hydrogen, NH.sub.2, C1-4 alkyl, C1-4 alkylamino or di(C1-4) alkylamino-; Y represents CH or N; Y" represents (a) CR.sup.y' R.sup.z' with R.sup.y' and R.sup.z' hydrogen, C1-6 alkyl, C.sub.3-8 cycloalkyl or C.sub.1-6 alkyl substituted with C.sub.3-8 cycloalkyl, or (b) N substituted with OR.sup.14 with R.sup.14 representing H, C.sub.1-4 alkyl or C.sub.1-4 alkyl substituted with COOH. Ar represents: ##STR2## One of R.sup.1 and R.sup.2 independently represent H, W as defined below or one of the groups (a) through (d) below, and the other represents H or W. Pharmaceutical compositions and methods of use are also included.
揭示了化学式I的化合物。##STR1## R.sup.13代表氢、NH.sub.2、C1-4烷基、C1-4烷基氨基或二(C1-4)烷基氨基;Y代表CH或N;Y"代表(a)CR.sup.y' R.sup.z',其中R.sup.y'和R.sup.z'代表氢、C1-6烷基、C.sub.3-8环烷基或C.sub.1-6烷基取代的C.sub.3-8环烷基,或(b)取代为OR.sup.14的N,其中R.sup.14代表H、C.sub.1-4烷基或C.sub.1-4烷基取代的COOH。Ar代表:##STR2## R.sup.1和R.sup.2中的一个独立代表H、下文定义的W或下列(a)至(d)中的一种基团,另一个代表H或W。还包括药物组合物和使用方法。